Phase 1 study of ADG126, a novel masked anti-CTLA-4 SAFEbody, that combines tumor-localized activation with strong T reg depletion and soft ligand blocking in patients with advanced solid tumors
Richardson, Gary Edward, Tolcher, Anthony W., Morris, Michelle Frances, de Souza, Paul L., Hamid, Anis, She, Xiaohong, Zhu, Lvyu, Wang, Hongyan, Zheng, Songmao, Liu, Guizhong, Li, Yan, Du, Fangyong Felix, Fischkoff, Steven, Gong, Hua, Zha, Jiping, Luo, Peter
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
A phase I, dose-escalation study of ADG106, a fully human anti-CD137 agonistic antibody, in subjects with advanced solid tumors or relapsed/refractory non-Hodgkin lymphoma
Zhang, Li, Zhao, Hongyun, Ma, Yuxiang, Zheng, Xin, Jiang, Ji, Zhang, Yang, Hong, Shaodong, Liu, Guizhong, She, Xiaohong, Ni, Qingjiang, Zhu, Lvyu, Zhu, Yi, Du, Fangyong Felix, Luo, Peter
Published in Journal of clinical oncology (20.05.2020)
Published in Journal of clinical oncology (20.05.2020)
Get full text
Journal Article
Safety and efficacy of abivertinib (AC0010), a third-generation EGFR tyrosine kinase inhibitor, in Chinese patients with EGFR-T790M positive non-small cell lung cancer (NCSLC)
Zhou, Qing, Wu, Lin, Feng, Luo, An, Tongtong, Cheng, Ying, Zhou, Jianying, Li, Junling, Feng, Ji Feng, Zhang, Li, Han, Baohui, Xu, Walson, Zhu, Lvyu, Xu, Li, Xu, Xiao, Luo, Feng Roger, Wu, Yi-Long
Published in Journal of clinical oncology (20.05.2019)
Published in Journal of clinical oncology (20.05.2019)
Get full text
Journal Article
753 A phase 1b/2 study of a novel anti-CTLA-4 NEObodyTM ADG116 monotherapy and in combination with toripalimab (Tori; Anti-PD-1 Antibody) in patients with advanced/metastatic solid tumors
Park, John, Hsien, Matthew, Richardson, Gary, Tolcher, Anthony, Chon, Hong Jae, Shin, Sang Joon, Lim, Ho Yeong, Anis Hamid, Li, Daneng, Shi, Kristine, Zheng, Songmao, Liu, Guizhong, Li, Ai, Zhu, Lvyu, Dai, Ruby, Peng, Wei, Lowe, Dana, Luo, Peter, Zha, Jiping
Published in Journal for immunotherapy of cancer (01.11.2022)
Published in Journal for immunotherapy of cancer (01.11.2022)
Get full text
Journal Article
Abstract CT227: Interim results of a phase 1b/2 study of ADG126 (a masked anti-CTLA-4 SAFEbody®) monotherapy and in combination with toripalimab (an anti-PD-1 antibody) in patients (pts) with advanced/metastatic solid tumors
Ariyapperuma, Mihitha, Park, John J., Khattak, Adnan, Richardson, Gary, Hamid, Anis, Morris, Michelle, Tolcher, Anthony W., Goh, Boon Cher, Lam, Justina, Chmielowski, Bartosz, She, Kristine, Zhang, Yanyan, Li, Ai, Zheng, Songmao, Liu, Guizhong, Zhu, Lvyu, Wang, Hongyan, Cui, Xiaoxing, Luo, Peter, Zha, Jiping
Published in Cancer research (Chicago, Ill.) (14.04.2023)
Published in Cancer research (Chicago, Ill.) (14.04.2023)
Get full text
Journal Article